Watch Out for Bleeding in These Cancer Patients on Extended Anticoagulation

By News Health
46 minutes Ago

(MedPage Today) — ORLANDO — Researchers identified four predictors of clinically relevant bleeding in patients receiving extended anticoagulation with apixaban (Eliquis) for cancer-associated venous thromboembolism (VTE).
Over a median follow…

Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118933

Author :

Publish date : 2025-12-10 18:27:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Last minute offer may avert next week's doctor strike

Gene Therapy Maintains Efficacy in Hemophilia B Out to 5 Years

FDA Opens Safety Review of Injectable RSV Drugs Approved for Babies and Toddlers

ACIP Chair's Hot Mic; Don't Deny COVID Vax Deaths; Abortion Drug Study Stalled

Inside the wild experiments physicists would do with zero limits

Phase I Vaccine Trial Shows Promise for Preventing Triple-Negative Breast Cancer